​

Viking Therapeutics Ownership | Who Owns Viking Therapeutics?

OverviewForecastFinancialsChartTranscripts

Viking Therapeutics Ownership Summary

Viking Therapeutics is owned by 67.89% institutional investors, 2.12% insiders, and 29.99% retail investors. Fmr is the largest institutional shareholder, holding 15.07% of VKTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 4.61% of its assets in Viking Therapeutics shares.

VKTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockViking Therapeutics67.89%2.12%29.99%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.72M15.07%$672.63M
Vanguard group10.17M9.17%$409.34M
Blackrock6.03M5.82%$319.45M
Blackrock funding, inc. /de5.87M5.30%$236.33M
State street5.12M4.95%$271.54M
Jpmorgan chase2.16M1.95%$86.82M
Geode capital management1.88M1.70%$75.70M
Braidwell lp1.48M1.33%$59.54M
Ameriprise financial1.48M1.33%$59.54M
Norges bank1.28M1.15%$51.46M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Apis capital advisors96.00K2.57%$3.86M
Profit investment management73.71K2.38%$2.97M
5am venture management189.59K1.82%$7.63M
Braidwell lp1.48M1.77%$59.54M
Toms capital investment management lp763.60K1.52%$40.48M
Artia global partners lp90.28K1.30%$3.63M
Lewis asset management41.27K1.27%$1.66M
Quantum private wealth85.92K1.11%$3.46M
Perceptive advisors995.89K1.10%$40.07M
Jw asset management45.00K0.86%$1.81M

Top Buyers

HolderShares% AssetsChange
State street5.12M0.01%1.80M
Norges bank1.28M0.01%1.28M
Ameriprise financial1.48M0.02%1.03M
Balyasny asset management860.45K0.05%860.45K
Toms capital investment management lp763.60K1.52%763.60K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---3.59M
Blackrock6.03M0.01%-2.25M
Massachusetts financial services co /ma/---1.36M
Perpetual---1.27M
International assets investment management18.28K0.06%-985.76K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.28M0.01%1.28M$51.46M
Toms capital investment management lp763.60K1.52%763.60K$40.48M
Raymond james financial618.47K0.01%618.47K$24.89M
Parallax volatility advisers268.88K0.02%268.88K$10.82M
Aquatic capital management209.13K0.23%209.13K$8.42M

Sold Out

HolderChange
Sachetta-1.00
Concord wealth partners-5.00
Capital advisors-8.00
Park place capital-9.00
Scarborough advisors-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025402-10.67%76,083,022-7.14%671.24%220-5.98%105-16.67%
Dec 31, 2024414-10.78%75,828,361-8.31%681.23%216-21.17%1146.54%
Sep 30, 20244606.48%82,562,3852.80%741.41%2728.80%106-4.50%
Jun 30, 20244280.71%80,251,5740.48%771.08%247-12.72%11124.72%
Mar 31, 202442593.18%79,870,2574.63%841.29%283154.96%8971.15%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O5.10M4.61%70.32K
Vanguard Total Stock Mkt Idx Inv3.43M3.06%85.06K
Vanguard US Total Market Shares ETF3.32M2.96%2.50K
Vanguard Small Cap Index2.68M2.38%18.88K
Fidelity Growth Compy Commingled Pl S2.26M2.02%-1.09M
SPDR® S&P Biotech ETF2.07M1.85%2.68K
Vanguard Institutional Extnd Mkt Idx Tr1.72M1.54%13.20K
Fidelity Growth Company Fund1.58M1.40%-712.20K
Vanguard Small Cap Growth Index Inv1.49M1.33%-3.15K
JPM US Mid Cap Growth-Composite1.15M1.02%394.72K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 31, 2025Rouan Sarah Kathryn-Buy$29.94K
Jan 06, 2025Lian Brian President & CEOSell$7.49M
Jan 06, 2025Lian Brian President & CEOSell$823.02K
Jan 06, 2025Mancini Marianna Chief Operating OfficerSell$2.10M
Jan 06, 2025Mancini Marianna Chief Operating OfficerSell$220.91K

Insider Transactions Trends

DateBuySell
2025 Q1-6
2024 Q4-11
2024 Q3-25
2024 Q2-9
2024 Q1-12

VKTX Ownership FAQ

Who Owns Viking Therapeutics?

Viking Therapeutics shareholders are primarily institutional investors at 67.89%, followed by 2.12% insiders and 29.99% retail investors. The average institutional ownership in Viking Therapeutics's industry, Biotech Stocks , is 63.96%, which Viking Therapeutics exceeds.

Who owns the most shares of Viking Therapeutics?

Viking Therapeutics’s largest shareholders are Fmr (16.72M shares, 15.07%), Vanguard group (10.17M shares, 9.17%), and Blackrock (6.03M shares, 5.82%). Together, they hold 30.07% of Viking Therapeutics’s total shares outstanding.

Does Blackrock own Viking Therapeutics?

Yes, BlackRock owns 5.82% of Viking Therapeutics, totaling 6.03M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 319.45M$. In the last quarter, BlackRock decreased its holdings by -2.248M shares, a -27.17% change.

Who is Viking Therapeutics’s biggest shareholder by percentage of total assets invested?

Apis capital advisors is Viking Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.57% of its assets in 96K Viking Therapeutics shares, valued at 3.86M$.

Who is the top mutual fund holder of Viking Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Viking Therapeutics shares, with 4.61% of its total shares outstanding invested in 5.1M Viking Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools